Association between weight fluctuation and the risk of metabolic dysfunction-associated steatotic liver disease

Figure 2 Flow chart. Metabolic dysfunction-associated steatotic liver disease development, total number of participants, exclusion criteria, final study group, incorporation of variables, and purpose of statistical analysis. HCC: Hepatocellular carcinoma; MASH: Metabolic dysfunction-associated steatohepatitis; MASL: Metabolic dysfunction-associated steatotic liver; MASLD: Metabolic dysfunction-associated steatotic liver disease; NHANES: National Health and Nutrition Examination Survey.